Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Medtronic
Dow
Baxter
McKinsey

Last Updated: June 29, 2022

Ipratropium bromide - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for ipratropium bromide and what is the scope of patent protection?

Ipratropium bromide is the generic ingredient in three branded drugs marketed by Boehringer Ingelheim, Actavis Mid Atlantic, Apotex Inc, Bausch And Lomb Inc, Landela Pharm, Luoxin Aurovitas, Mylan Speciality Lp, Nephron, Ritedose Corp, Roxane, Sun Pharm, Teva Pharms Usa, Watson Labs, Zennova, Bausch And Lomb, and Hikma, and is included in twenty-six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Ipratropium bromide has ten patent family members in nine countries.

There are eight drug master file entries for ipratropium bromide. Sixteen suppliers are listed for this compound.

Drug Sales Revenue Trends for ipratropium bromide

See drug sales revenues for ipratropium bromide

Recent Clinical Trials for ipratropium bromide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ohio State UniversityPhase 4
Nationwide Children's HospitalPhase 4
University of Nevada, Las VegasPhase 4

See all ipratropium bromide clinical trials

Pharmacology for ipratropium bromide
Drug ClassAnticholinergic
Mechanism of Action Cholinergic Antagonists
Medical Subject Heading (MeSH) Categories for ipratropium bromide

US Patents and Regulatory Information for ipratropium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc IPRATROPIUM BROMIDE ipratropium bromide SPRAY, METERED;NASAL 076155-001 Apr 18, 2003 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Bausch And Lomb IPRATROPIUM BROMIDE ipratropium bromide SPRAY, METERED;NASAL 076025-001 Mar 31, 2003 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mylan Speciality Lp IPRATROPIUM BROMIDE ipratropium bromide SPRAY, METERED;NASAL 075553-001 Mar 31, 2003 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hikma IPRATROPIUM BROMIDE ipratropium bromide SPRAY, METERED;NASAL 076598-001 Nov 5, 2003 AB RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Bausch And Lomb IPRATROPIUM BROMIDE ipratropium bromide SPRAY, METERED;NASAL 076103-001 Mar 31, 2003 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Apotex Inc IPRATROPIUM BROMIDE ipratropium bromide SPRAY, METERED;NASAL 076156-001 Apr 18, 2003 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Sun Pharm IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 207903-001 Jan 3, 2017 AN RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ipratropium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim ATROVENT HFA ipratropium bromide AEROSOL, METERED;INHALATION 021527-001 Nov 27, 2004 See Plans and Pricing See Plans and Pricing
Boehringer Ingelheim ATROVENT HFA ipratropium bromide AEROSOL, METERED;INHALATION 021527-001 Nov 27, 2004 See Plans and Pricing See Plans and Pricing
Boehringer Ingelheim ATROVENT ipratropium bromide AEROSOL, METERED;INHALATION 019085-001 Dec 29, 1986 See Plans and Pricing See Plans and Pricing
Boehringer Ingelheim ATROVENT HFA ipratropium bromide AEROSOL, METERED;INHALATION 021527-001 Nov 27, 2004 See Plans and Pricing See Plans and Pricing
Boehringer Ingelheim ATROVENT HFA ipratropium bromide AEROSOL, METERED;INHALATION 021527-001 Nov 27, 2004 See Plans and Pricing See Plans and Pricing
Boehringer Ingelheim ATROVENT HFA ipratropium bromide AEROSOL, METERED;INHALATION 021527-001 Nov 27, 2004 See Plans and Pricing See Plans and Pricing
Boehringer Ingelheim ATROVENT HFA ipratropium bromide AEROSOL, METERED;INHALATION 021527-001 Nov 27, 2004 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ipratropium bromide

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 2009037085 See Plans and Pricing
Japan 5436430 See Plans and Pricing
Germany 102007045438 Inhalier-Gerät See Plans and Pricing
Poland 2203205 See Plans and Pricing
Denmark 2203205 See Plans and Pricing
Japan 2010538780 See Plans and Pricing
Hungary E025069 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Johnson and Johnson
Moodys
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.